Indication
Facial lentigo
Facial lentigo refers to a benign, acquired hyperpigmented macule or thin plaque occurring on the integumentary system of the face, most frequently presenting as a solar lentigo secondary to chronic ultraviolet radiation exposure. Read more about Facial lentigo
7 drugs 7 manufacturers
Drugs that treat it
Common Facial lentigo therapies.
TAZAROTENE
TAZAROTENE
TAZAROTENE
TAZAROTENE
TAZAROTENE
TAZAROTENE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonFacial lentigo refers to a benign, acquired hyperpigmented macule or thin plaque occurring on the integumentary system of the face, most frequently presenting as a solar lentigo secondary to chronic ultraviolet radiation exposure.
It primarily affects older adults and individuals with fair skin types, though it can occur across diverse populations with significant cumulative photoaging or as part of rare genetic syndromes.
Clinically, lesions appear as well-circumscribed, light-to-dark brown, round or irregular macules that persist independently of seasonal sunlight variations.
Pathophysiologically, the condition is defined by localized epidermal hyperplasia with elongation of the rete ridges, marked basal layer hyperpigmentation, and increased melanin production with or without a slight, non-atypical proliferation of basal melanocytes.
- dermnetnz.org
Facial lentigo refers to a benign, acquired hyperpigmented macule or thin plaque occurring on the integumentary system of the face, most frequently presenting as a solar lentigo secondary to chronic ultraviolet radiation exposure Clinically, lesions appear as well-circumscribed, light-to-dark brown, round or irregular macules that persist independently of seasonal sunlight variations
- dermnetnz.org
Facial lentigo refers to a benign, acquired hyperpigmented macule or thin plaque occurring on the integumentary system of the face, most frequently presenting as a solar lentigo secondary to chronic ultraviolet radiation exposure It primarily affects older adults and individuals with fair skin types, though it can occur across diverse populations with significant cumulative photoaging or as part of rare genetic syndromes Pathophysiologically, the condition is defined by localized epidermal hyper...
- nih.gov
It primarily affects older adults and individuals with fair skin types, though it can occur across diverse populations with significant cumulative photoaging or as part of rare genetic syndromes
- dermnetnz.org
Clinically, lesions appear as well-circumscribed, light-to-dark brown, round or irregular macules that persist independently of seasonal sunlight variations
- dermnetnz.org
Pathophysiologically, the condition is defined by localized epidermal hyperplasia with elongation of the rete ridges, marked basal layer hyperpigmentation, and increased melanin production with or without a slight, non-atypical proliferation of basal melanocytes
Personalize your experience
Follow Facial lentigo and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.